![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 43, 30778-30783, October 22, 1999
From the Caspases are key effectors of programmed cell
death in metazoans. In Drosophila, four caspases have been
described so far. Here we describe the identification and
characterization of the fifth Drosophila caspase, DECAY.
DECAY shares a high degree of homology with the members of the
mammalian caspase-3 subfamily, particularly caspase-3 and caspase-7.
DECAY lacks a long prodomain and thus appears to be a class II effector
caspase. Ectopic expression of DECAY in cultured cells induces
apoptosis. Recombinant DECAY exhibited substrate specificity similar to
the mammalian caspase-3 subfamily. Low levels of decay
mRNA are ubiquitously expressed in Drosophila embryos
during early stages of development but its expression becomes somewhat
spatially restricted in some tissues. During oogenesis
decay mRNA was detected in egg chambers of all stages
consistent with a role for DECAY in apoptosis of nurse cells.
Relatively high levels of decay mRNA are expressed in
larval salivary glands and midgut, two tissues which undergo histolysis during larval/pupal metamorphosis, suggesting that DECAY may play a
role in developmentally programmed cell death in
Drosophila.
Programmed cell death in metazoans is mediated by caspases, a
family of cysteine proteases, which cleave their substrates following
an Asp residue (1-5). A number of caspases have been described in both
vertebrates and invertebrates. To date fourteen caspases have been
cloned in mammals, some of which play a critical role in apoptosis,
whereas others seem mainly involved in the processing and activation of
proinflammatory cytokines (1-5). Although four caspases exist in the
nematode Caenorhabditis elegans, only one, CED-3, is
essential for all developmentally programmed cell death (6, 7). In
Drosophila melanogaster four caspases, named DCP-1,
DREDD/DCP-2, drICE and DRONC, have been reported so far (8-12). Among
these caspases, DREDD and DRONC contain long prodomains carrying death
effector domains and a caspase recruitment domain (CARD), respectively,
suggesting that these two caspases may act as upstream (class I)
caspases. On the other hand, DCP-1 and drICE lack long prodomains and
are thus similar to downstream effector (class II) caspases in mammals.
Currently, loss of function mutants are only available for dcp-1.
dcp-1 mutation results in larval lethality and melanotic tumors
(8). Additionally, DCP-1 is required for Drosophila
oogenesis, as dcp-1 mutants show a defect in transfer of
nurse cell cytoplasmic contents to developing oocytes (13). The
transcript for dredd accumulates in embryonic cells
undergoing programmed cell death and in nurse cells in the ovary at a
time that coincides with nurse cell death (9). dronc mRNA is widely expressed during development and appears to be up-regulated by ecdysone in larval salivary glands and midgut before
histolysis of these tissues (12). The precise roles of drICE and DRONC
in programmed cell death in Drosophila have not been
established. However, in vitro antibody depletion
experiments suggest that drICE is required for apoptotic activity in
the S2 Drosophila cell line (14). Accumulation of
dronc mRNA in salivary glands and midgut may be required
to sensitize these tissues for deletion by apoptosis during
metamorphosis. These recent studies suggest that specific caspases may
mediate tissue and stage specific programmed cell death during
Drosophila development.
To fully understand the role of various caspases in cell physiology, it
is important to identify all caspases in a given model organism. In
this study, we describe the characterization of DECAY, the fifth
Drosophila caspase. DECAY is highly similar to class II
executioner caspases such as mammalian caspase-3 and caspase-7. We show
that decay gene expression is widespread in developing fly
embryos, and DECAY has substrate specificity similar to caspase-3 subfamily of caspases.
Identification and Sequencing of Decay cDNA--
DECAY was
identified through a homology search with mammalian caspases as a
GenBankTM expressed sequence tag (accession number
AI259958). The expressed sequence tag clone was obtained from Berkley
Drosophila Genome Project in pOT2 vector and was sequenced
in full. This clone (clone ID LP3492) contained a 1,797-base pair
insert, which was much longer than the 1.1-kilobase predicted size of
the transcript (see below). A careful examination of the sequence
suggested that ~700 base pair of the 3' sequence in this clone may be
derived from fusion of a heterologous cDNA. The 5' 1,101 base pair
of the sequence, including a 20 residue poly(A) tail, is likely to represent the authentic full-length decay cDNA
containing the entire coding region. This sequence has been deposited
in the GenBankTM data base under accession number
AF130469.
Plasmid Constructs--
The 0.85-kilobase coding region of
decay was amplified from the original pOT2-decay
vector by polymerase chain reaction using Pwo polymerase
(Roche Biochemicals) and the following oligonucleotides: Primer A,
5'-GGCGGATCCGCCGCCATGGCACCAAGATCCCATACG; and
Primer B,
5'-CCGGAATTCTCACTTGTCATCGTCGTCCTTGTAGTCGGTCTTGGGCTTAACACG
(nucleotides corresponding to decay sequence are
underlined). Primer A contained a consensus Kozak sequence that
required alteration of the initiation site from the original sequence
and a BamHI cloning site. Primer B contained an
EcoRI site and sequence encoding a FLAG tag. Amplified product was purified and cloned directionally into pcDNA3
(Invitrogen). The catalytic Cys150 residue of DECAY was
mutated to a Gly residue by Quickchange mutagenesis (Stratagene) using
pOT2-decay as template. Mutant decay cDNA
encoding DECAY(C150G) protein was cloned directionally into pcDNA3
as described above. Primer C,
5'-GCGAATTCCATATGCCACCAAGATCCCAT containing a
NdeI site and primer D,
5'-GGCGGATCCCGGGTCTTGGGCTTAACACGCAG containing a
BamHI site (sequence corresponding to decay
is underlined in both primers) were used to amplify wild type and
catalytic cysteine mutant DECAY for directional cloning into pET32b
vector (Novagen).
Recombinant Caspases and Caspase Assays--
Recombinant DECAY
was generated by transformation of Escherichia coli BL21
cells with DECAY-6xHis or DECAY(C150G)-6xHis constructs in pET32b.
Overnight cultures were subcultured 1 in 10 and grown at 37 °C for
2 h. Cultures were induced with 1 mM
isopropyl-1-thio- Transient Transfection--
NIH3T3 cells were maintained in
Dulbecco's modified Eagle's medium with 10% fetal calf serum. 293T
cells were grown in RPMI with 10% fetal calf serum. For cell death
assays, 2 × 105 cells were plated per 35-mm dish the
day before transfection. 1.5 µg of pcDNA3-decay,
pcDNA3-decay (C150G) or empty vector, were cotransfected
with 0.5 µg of a Northern and in Situ mRNA Analysis--
Total RNA from
various developmental stages of Drosophila or adult flies
was prepared using RNAzol B according to the manufacturer's (Tel-Test
Inc.) protocol. Poly(A)+-enriched RNA was prepared using
oligo dT magnetic beads (Dynal). Approximately 20 µg of total RNA or
1-2 µg of poly(A)+ RNA was electrophoresed onto a
2.2-M formaldehyde gel and transferred to Biodyne A nylon
membrane (Pall Corp.). The blot was hybridized to a
32P-labeled decay cDNA coding region probe
and exposed to Kodak XAR-5 film. For in situ RNA analysis,
antisense and sense digoxygenin-labeled riboprobes were prepared using
appropriate RNA polymerases from linearized decay cDNA
clone. Digoxygenin labeling was performed according to the
manufacturer's instructions (Roche Molecular Biochemicals). In
situ hybridization to Drosophila embryos and larval
tissues was essentially as described (23) with some modifications. Embryos and dissected larval tissues were fixed in 0.1 M
HEPES, 50 mM EGTA, 0.01% Nonidet P-40, 4% formaldehyde,
pH 6.9 for 20 min. The proteinase step was omitted. Dissected ovaries
from 3-day-old adult females were fixed as described for embryos and
treated with 50% ethanol and 50% xylene for 30 min, washed in
ethanol, then in methanol, and finally in phosphate-buffered saline
with 0.01% Triton X-100 (PBS-T). Ovaries were then refixed for 25 min in 4% paraformaldehyde and treated with proteinase K (5 µg/ml) for 8 min at room temperature. After hybridization, nonspecifically bound
probe was removed by digestion with RNase A (125 µg/ml in PBS-T) for
1 h at 37 °C. Hybridization was detected using the alkaline
phosphatase-coupled secondary antibody detection system according to
the manufacturer's instructions (Roche Molecular Biochemicals).
Identification of DECAY--
While searching for new molecules
with homology to various mammalian caspases, using TBLASTN program, we
identified an expressed sequence tag in the GenBankTM data
base which encoded a partial caspase-like molecule. The sequencing of
the entire clone revealed that the cDNA has an open reading frame
of 287 amino acid residues with a high degree of homology to mammalian
caspases, particularly those related to the caspase-3 subfamily (Fig.
1). We named this new molecule DECAY, for
Drosophila executioner
caspase related to Apopain/Yama. DECAY shares approximately 39% identity (54% similarity) with Spodoptera frugiperda caspase-1, 37% identity (56%
similarity) with mammalian caspase-3 and caspase-7, 35% identity
(53-55% similarity) with Drosophila caspases DCP-1 and
drICE, and 32-33% identity (48-52% similarity) with caspase-8 and
caspase-10.
An alignment of all known Drosophila caspases showed that
DECAY is most homologous to an unpublished putative caspase encoded by
genomic sequence contained in a data base entry (accession number
AC005466), followed by DCP-1 and drICE (Fig. 1, B and C). Similar to drICE and DCP-1, DECAY lacks a long
amino-terminal prodomain. DECAY is distantly related to DRONC and
DREDD, the two class I Drosophila caspases. Overall, DECAY
is more similar to S. frugiperda caspase-1 and mammalian
caspase-3 and caspase-7 than all known Drosophila caspases.
Interestingly, DECAY is the only Drosophila caspase that
carries a QACRG sequence encompassing the putative catalytic
Cys150 residue. In this respect, it is similar to the
majority of mammalian caspases, including caspase-3 and caspase-7.
By hybridizing to a filter containing Drosophila genomic P1
clones, we localized the decay gene to the Fas1 contig
located within chromosome region 89C6-D4 (data not shown). None of the other published Drososphila caspase genes map to this region.
DECAY Has a Substrate Specificity Similar to the Caspase-3
Subfamily--
To confirm that DECAY is indeed a caspase, we expressed
full-length wild-type and C150G mutant DECAY fused to 6xHis in E. coli. The majority of the protein expressed in E. coli
was insoluble and became inactive upon attempts to purify under both
native and denaturing conditions (data not shown). Therefore, we
analyzed caspase activity in the soluble fraction of bacterial extracts using fluorogenic peptide substrates. DECAY did not show significant activity on caspase-1 substrate YVAD-amc, however, it efficiently cleaved caspase-3 substrate DEVD-amc (Fig.
2A). Interestingly, DECAY was
substantially more active on the pentapeptide substrate VDVAD-amc. This
peptide is a preferred substrate for caspase-2, which requires a
P5 residue (24). However, in our hands, VDVAD-amc was also
a much better substrate for caspase-3, as compared with DEVD-amc (Fig.
2A). As expected, the C150G mutant DECAY did not exhibit any
appreciable caspase activity.
Poly(ADP-ribose) polymerase (PARP) is one of the key cellular
substrates of caspase-3 (25, 26). To check whether PARP can serve as a
substrate for DECAY in vitro, we incubated a
35S-labeled truncated PARP protein that carries the
caspase-3 cleavage site (18) with recombinant DECAY and measured its
cleavage by electrophoresis and autoradiography. As shown in Fig.
2B, this protein was efficiently cleaved by DECAY. The
cleavage products generated by DECAY were identical in size to those
generated by caspase-3 suggesting that both caspases cleave following
the same DEVD sequence in PARP.
Ectopic Expression of DECAY in Cultured Cells--
Many caspases,
when overexpressed in cultured cells, induce apoptosis to some degree.
We therefore analyzed whether DECAY is able to induce apoptosis in
transfected cells. In 293T cells, at 24 h following transfections,
around 35% of cells transfected with the wild-type decay
construct showed apoptotic morphology when compared with cells
transfected with the empty vector or an expression construct carrying
the C150G mutant DECAY (Fig. 3A). In NIH3T3 cells, by
24 h post-transfection, a small number (~10%) of cells
transfected with the wild-type decay were apoptotic (Fig.
3A). By 48 h, decay transfected cells
showing apoptotic morphology increased slightly to around 15% (data
not shown). This level of cell death induced by DECAY overexpression is
similar to that induced by caspase-3 under similar conditions (22, 27). We also assessed the effect of DECAY overexpression in MCF-7 cells and
Drosophila S2 cells. In both cases levels of apoptosis
similar to those seen in NIH3T3 cells were observed (data not
shown).
Using FLAG-tagged DECAY, we further investigated the subcellular
localization of DECAY protein in transfected cells by
immunofluorescence analysis employing an anti-FLAG antibody and a
fluorescein isothiocyanate-coupled secondary antibody. In both NIH3T3
and 293T cells, most of the DECAY-FLAG protein was present in the
cytoplasmic compartment (Fig. 3B).
decay mRNA Expression During Drosophila Development--
In
RNA blots, decay was present as an approximately
1.1-kilobase transcript in most developmental stages, larvae, pupae,
and in the adult fly (Fig. 4). Relatively
high levels of decay transcript were detected in the adult
fly (Fig. 4B). We further analyzed the expression pattern of
decay during fly development by in situ hybridization to Drosophila embryos and larval tissues using
a digoxigenin-labeled antisense mRNA probe (Fig.
5). decay is expressed at low
levels throughout embryogenesis and shows no specific up-regulation at
stage 11 (Fig. 5, A-C, and data not shown) when
programmed cell death first becomes evident in Drosophila
(28). decay mRNA was present in stage 1-4 syncitial
embryos (not shown), suggesting that it is maternally deposited into
the embryo, because zygotic expression does not begin before stage 5 (29). In stage 6-7 cellularized embyros, decay mRNA is
ubiquitously expressed (Fig. 5B), but in later stages
decay mRNA is present at higher levels within the gut
(Fig. 5C). We also examined the expression of
decay in third instar larval tissues and during oogenesis
(Fig. 5, E-L). High levels of decay
expression was observed in salivary glands and midgut tissue from third
instar larvae (Fig. 5, E and F), preceding the
onset of apoptosis in these tissues, which occurs after pupariation
(30). Only very low levels of decay expression were observed
throughout third instar larval eye imaginal discs and brain lobes (Fig.
5, G and H), which contain apoptotic cells at
this stage (31). However, up-regulation of decay expression was not observed in eye disc or brain lobe cells undergoing
apoptosis.
During oogenesis decay mRNA is detected in egg chambers
of all stages but was present at higher levels in the nurse cells after
stage 10a (Fig. 5I and data not shown). In stage 12 egg chambers, decay mRNA was absent from nurse cells that
have initiated apoptosis and present at high levels in the developing
oocyte (Fig. 5, J and K), consistent with dumping
of the nurse cell cytoplasm into the oocyte that occurs at this stage
(32). The expression of decay mRNA in egg chambers is
consistent with a role for decay in apoptosis of the nurse cells.
We have previously shown that dronc mRNA is up-regulated
when isolated salivary glands and midgut from second instar larvae are
exposed to ecdysone (12). Because larval salivary glands and midgut
show relatively high expression of decay transcript, it was
of interest to check whether decay is also regulated by ecdysone. As shown in Fig. 6, no
up-regulation of decay transcript was evident in ecysone
treated salivary glands and midgut. Under similar conditions,
dronc transcript was up-regulated at least 5-fold in
response to ecdysone (Fig. 6).
Conclusions--
We have described here preliminary
characterization of a new Drosophila caspase DECAY. Presence
of multiple caspases in Drosophila suggest that cell death
pathways in the fly are likely to be complex. DECAY is most similar to
caspase-3-like effector caspases and shares a similar substrate
specificity. Low levels of decay transcript are widely
expressed during Drosophila embryogenesis. Higher expression of decay mRNA in larval salivary glands and midgut
suggests a possible role for DECAY in programmed deletion of these
obsolete tissues during metamorphosis and tissue remodeling.
Additionally, moderate expression of decay mRNA in nurse
cells suggests a possible role for DECAY in nurse cell death. Because
high levels of decay transcript are also found in the adult
animals, DECAY may also be involved in regulating the normal cell
turnover in the adult. Generation of loss-of-function decay
mutant, or RNA ablation studies would shed further light on the role of
DECAY in programmed cell death in Drosophila.
Mammalian caspases have been proposed to belong to two groups. The
upstream, initiator, or class I caspases carrying specific protein-protein interaction domains are autoactivated when several molecules are clustered in close proximity following recruitment via
specific adaptors (33). The downstream, effector, or class II caspases
require processing by class I caspases, but once activated these
caspases (e.g. caspase-3) can also mediate the processing of
some class I caspases, which probably serves as a signal amplification mechanism (34). Because DECAY is a class II caspase, we analyzed whether it can be processed by the known Drosophila caspases
(data not shown). However, so far we have been unable to identify a protease capable of cleaving DECAY. Further studies are required to
delineate the mechanism of DECAY activation.
We thank Paul Colussi for helpful discussions
and comments on the manuscript.
*
This work was supported in part by grants from the Wellcome
Trust and Australian Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF130469.
¶
Supported by a Commonwealth Postgraduate Award.
**
Wellcome Trust Senior Fellow in Medical Science.
The abbreviations used are:
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid;
PARP, poly(ADP-ribose) polymerase.
DECAY, a Novel Drosophila Caspase Related to
Mammalian Caspase-3 and Caspase-7*
§¶,
,
,
**, and
§**
Hanson Centre for Cancer Research, Institute
of Medical and Veterinary Science, Frome Road, Adelaide, SA 5000, Australia and the Departments of
Genetics and
§ Medicine, the University of Adelaide, Adelaide SA 5001, Australia
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-D-galactopyranoside and grown for a
further 3 h. Cells were pelleted and lysed by sonication in assay
buffer (0.1M HEPES, pH 7.0, 10% polyethylene glycol 4000, 0.1%
CHAPS,1 10 mM
dithiothreitol). Recombinant DRONC, caspase-2, and caspase-3 were
prepared as described previously (12, 15-17). Cleared E. coli lysates containing active caspases were incubated with 50 µM fluorogenic peptide substrates and assayed for caspase
activity as described previously (18, 19). YVAD-amino-methylcoumaride (-amc), and DEVD-amc were purchased from Enzyme Systems Inc., Livermore, CA, and VDVAD-amc was from California Peptide Research Inc.
-galactosidase expression plasmid (pEF-
gal)
(20). All transfections were carried out using Fugene6 transfection
reagent (Roche Biochemicals) according to manufacturer's instructions.
Cells were fixed and stained with X-gal at 24 h or 48 h
post-transfection, and
-galactosidase positive cells were scored for
apoptotic morphology as described previously (20-22). At 24 h
post-transfection, subcellular localization of DECAY was determined by
fixing cells in 47.5% methanol, 47.5% acetone, 5% formaldehyde, and
staining with anti-FLAG monoclonal antibody (Sigma), followed by
anti-mouse-fluorescein isothiocyanate (Roche Biochemicals) for 30 min
each. Cells were viewed using a fluorescence microscope (Olympus
BH2-RFCA).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (60K):
[in a new window]
Fig. 1.
DECAY sequence and its relationship to other
known Drosophila caspases. A, deduced
amino acid sequence of DECAY consists of 287 amino acid residues. The
pentapeptide sequence QACRG, encompassing the catalytic
Cys150, is underlined. B, an amino
acid sequence alignment of the known Drosophila caspases.
AC005466 is the GenBankTM accession number of contig of
Drosophila genomic sequence that contains the coding region
for a putative caspase. The partial sequence for this caspase shown
here, which lacks the amino-terminal region, is derived from a single
exon. Alignments were obtained using CLUSTAL W program at European
Bioinformatics Institute. Residues conserved in at least five caspases
are shown in black boxes. Similar residues in at least five
caspases or those identical in four caspases are shown in gray
boxes. C, phylogenetic relationship between various
Drosophila caspases.

View larger version (22K):
[in a new window]
Fig. 2.
DECAY has a substrate specificity similar to
caspase-3-like caspases. A, activity of recombinant
DECAY on fluorogenic peptide substrates. E. coli lysates
containing recombinant caspases were incubated with various fluorogenic
caspase substrates at 37 °C for 30 min and release of -amc was
monitored by a fluorimeter. B, cleavage of a truncated PARP
protein containing the caspase-3 cleavage site DEVD by DECAY. In
vitro translated 35S-labeled PARP protein was
incubated with recombinant DECAY or caspase-3 for 3 h at 37 °C.
Cleavage products were electrophoresed on SDS-polyacrylamide gels,
transferred to nitrocellulose membranes, and autoradiographed. The
truncated PARP cDNA translates into a 38-kDa protein, which when
cleaved following a DEVD sequence, generates 24- and 14-kDa fragments.
As expected, the catalytically inactive C150G mutant DECAY does not
cleave PARP, whereas, DECAY and caspase-3 generate identical sized
fragments of 24 and 14 kDa.

View larger version (59K):
[in a new window]
Fig. 3.
A, effect of DECAY expression in
transfected mammalian cells. Various expression constructs were
co-transfected with pEF-
gal into 293T and NIH3T3 cells by
lipofection. At 24 h post-transfection cells were fixed, stained
with X-gal, and blue cells observed for apoptosis. Bars represent
apoptotic cells as percentage of total
-galactosidase +ve cells
±S.E. At least 300 blue cells were scored for each dish. The data
shown were derived from three independent experiments. B,
ectopically expressed DECAY localizes mainly to a cytoplasmic
compartment in transfected cells. NIH3T3 or 293T cells were transfected
with the empty vector (left side panels) or a DECAY-FLAG
(right side panels) expression construct. At 18 h
post-transfection, cells were fixed, and expression of DECAY-FLAG
protein detected using an anti-FLAG primary anitibody followed by a
fluorescein isothiocyanate-coupled secondary antibody. Cells were
observed and photographed using a fluorescence microscope. Although
DECAY expression induces significant cell death in both cell lines (as
shown in Fig. 3A), selected fields with mostly nonapoptotic
cells are shown in this figure.

View larger version (51K):
[in a new window]
Fig. 4.
Expression of decay mRNA. Approximately 20 µg of total RNA (A)
or 1-2 µg of poly(A)+-enriched RNA (B)
isolated from various developmental stages and adult flies were
analyzed by Northern blotting using decay open reading frame
as a probe. decay transcript is detected as a single
approximately 1.1-kilobase band in all samples examined. The
lower panels in both A and B depict
portions of the ethidium bromide-stained gels corresponding to
ribosomal RNA bands before transfer to membrane.

View larger version (60K):
[in a new window]
Fig. 5.
In situ mRNA analysis of
decay expression during Drosophila development. decay mRNA was detected by
in situ hybridization with a digoxigenin-labeled antisense
mRNA probe. A, a stage 5 syncitial embryo showing
uniformly low levels of decay expression; B, a
stage 7 embryo showing decay expression throughout the
embryo. The regions of higher staining are due to tissue folding.
C, a stage 13 embryo showing decay expression
occurs at higher levels in the middle of the embryo corresponding to
the gut tissue but is absent from the dorsal cells of the amnioserosa.
D, a stage 8 embryo hybridized with the decay
sense control probe showing no staining. E, a third instar
larval salivary gland showing high levels of decay mRNA.
F, a third instar midgut showing high levels of
decay expression. G, a late third instar eye
imaginal disc showing very low levels of decay expression.
H, brain lobes from third instar larvae showing ubiquitous
low level of decay expression. decay sense
control on late third instar larval tissues showed no staining (data
not shown). I, a stage 10a adult egg chamber showing high
expression of decay mRNA in the nurse cells but not in
the oocyte (on the right). J, adult egg chambers showing
that decay mRNA is increased at stage 9 compared with
earlier stages. K, Hoechst 33258 staining of DNA in adult
egg chambers, showing the morphology of nuclei. At stage 12 the nurse
cells (see large nuclei on the left in K) are undergoing
apoptosis, and decay mRNA has been dumped into the
oocyte (shown in J). The oocyte is surrounded by follicle
cells (see small nuclei in K), whereas the germinal vesicle
is out of the plane of focus. L, decay sense
control on adult egg chambers showing no staining.

View larger version (54K):
[in a new window]
Fig. 6.
decay transcript is not
up-regulated by ecdysone. Salivary glands and midgut were
dissected out of larvae at the indicated stages and either treated with
1 mM ecdysone for 1 h, or left untreated. Total RNA
prepared from untreated and ecdysone-treated tissues was subjected to
Northern blot analysis using decay and dronc
cDNA probes. The lower panel depicts a portion of the
ethidium bromide-stained gel before transfer to membrane. The last lane
in the gel contains total RNA from early pupae, which express
relatively high levels of dronc transcript.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES

To whom correspondence should be addressed: The Hanson Centre
for Cancer Research, Institute of Medical and Veterinary Science, P.O.
Box 14, Rundle Mall, Adelaide, SA 5000, Australia. Tel.: 61-8-8222-3738; Fax: 61-8-8222-3139; E-mail:
sharad.kumar@imvs.sa.gov.au.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Kumar, S.,
and Lavin, M. F.
(1996)
Cell Death Diff.
3,
255-267
2.
Nicholson, D. W.,
and Thornberry, N. A.
(1997)
Trends Biochem Sci.
22,
299-306[CrossRef][Medline]
[Order article via Infotrieve]
3.
Cryns, V.,
and Yuan, J.
(1998)
Genes Dev.
12,
1551-1570 4.
Kumar, S.
(1999)
Clin. Exp. Pharmacol. Physiol.
26,
295-303[CrossRef][Medline]
[Order article via Infotrieve]
5.
Rathmell, J. C.,
and Thomson, C. B.
(1999)
Annu. Rev. Immunol.
17,
181-828
6.
Metzstein, M. M.,
Stanfield, G. M.,
and Horvitz, H. R.
(1998)
Trends Genet.
14,
410-416[CrossRef][Medline]
[Order article via Infotrieve]
7.
Shaham, S.
(1998)
J. Biol. Chem.
273,
35109-35117 8.
Song, Z.,
McCall, K.,
and Steller, H.
(1997)
Science
275,
536-540 9.
Chen, P.,
Rodriguez, A.,
Erskine, R.,
Thach, T.,
and Abrams, J. M.
(1998)
Dev. Biol.
201,
202-216[CrossRef][Medline]
[Order article via Infotrieve]
10.
Inohara, N.,
Koseki, T.,
Hu, Y.,
Chen, S.,
and Nunez, G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
10717-10722 11.
Fraser, A. G.,
and Evan, G. I.
(1997)
EMBO J.
16,
2805-2813[CrossRef][Medline]
[Order article via Infotrieve]
12.
Dorstyn, L.,
Colussi, P.,
Quinn, L. M.,
Richardson, H.,
and Kumar, S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4307-4312 13.
McCall, K.,
and Steller, H.
(1998)
Science
279,
230-234 14.
Fraser, A. G.,
McCarthy, N. J.,
and Evan, G. I.
(1997)
EMBO J.
16,
6192-6199[CrossRef][Medline]
[Order article via Infotrieve]
15.
Fernandes-Alnemri, T.,
Litwac, G.,
and Alnemri, E. S.
(1995)
Cancer Res.
55,
2737-2742 16.
Harvey, N. L.,
Trapani, J. A.,
Fernandes-Alnemri, T.,
Litwack, G.,
Alnemri, E. S.,
and Kumar, S.
(1996)
Genes Cells
1,
673-685[Abstract]
17.
Song, Q.,
Lees-Miller, S. P.,
Kumar, S.,
Zhang, N.,
Chan, D. W.,
Smith, G. C. M.,
Jackson, S. P.,
Alnemri, E. S.,
Litwack, G.,
Khanna, K. K.,
and Lavin, M. F.
(1996)
EMBO J.
15,
3238-3246[Medline]
[Order article via Infotrieve]
18.
Harvey, N. L.,
Butt, A. J.,
and Kumar, S.
(1997)
J. Biol. Chem.
272,
13134-13139 19.
Butt, A. J.,
Harvey, N. L.,
Parasivam, G.,
and Kumar, S.
(1998)
J. Biol. Chem.
273,
6763-6768 20.
Kumar, S.,
Kinoshita, M.,
Noda, M.,
Copeland, N. G.,
and Jenkins, N. A.
(1994)
Genes Dev.
8,
1613-1626 21.
Kumar, S.,
Kinoshita, M.,
Dorstyn, L.,
and Noda, M.
(1997)
Cell Death Diff.
4,
378-387[CrossRef]
22.
Dorstyn, L.,
and Kumar, S.
(1997)
Cell Death Diff.
4,
570-579[CrossRef][Medline]
[Order article via Infotrieve]
23.
Lehner, C. F.,
and O'Farrell, P. H.
(1989)
Cell
56,
957-968[CrossRef][Medline]
[Order article via Infotrieve]
24.
Talanian, R. V.,
Quinlan, C.,
Trautz, S.,
Hackett, M. C.,
Mankovich, J. A.,
Banach, D.,
Ghayur, T.,
Brady, K. D.,
and Wong, W. W.
(1997)
J. Biol. Chem.
272,
9677-9682 25.
Tewari, M.,
Quan, L. T.,
O'Rourke, K.,
Desnoyers, S.,
Zeng, Z.,
Beidler, D. R.,
Poirier, G. G.,
Salvesen, G. S.,
and Dixit, V. M.
(1995)
Cell
81,
1-20[CrossRef][Medline]
[Order article via Infotrieve]
26.
Nicholson, D. W.,
Ali, A.,
Thornberry, N. A.,
Vaillancourt, J. P.,
Ding, C. K.,
Gallant, M.,
Gareau, Y.,
Griffin, P. R.,
Labelle, M.,
Lazebnik, Y. A.,
Munday, N. A.,
Raju, S. A.,
Smulson, M. E.,
Yamin, T.-T., Yu, V. L.,
and Miller, D. K.
(1995)
Nature
376,
37-43[CrossRef][Medline]
[Order article via Infotrieve]
27.
Colussi, P. A.,
Harvey, N. L.,
Shearwin-Whyatt, L. M.,
and Kumar, S.
(1998)
J. Biol. Chem.
273,
26566-26570 28.
Abrams, J. M.,
White, K.,
Fessler, L. I.,
and Steller, H.
(1993)
Development
117,
29-43[Abstract]
29.
Edgar, B. A.,
and Schubiger, G.
(1986)
Cell
44,
871-877[CrossRef][Medline]
[Order article via Infotrieve]
30.
Jiang, C.,
Baehrecke, E. H.,
and Thummel, C. S.
(1997)
Development
124,
4673-4683[Abstract]
31.
Wolff, T.,
and Ready, D. F.
(1991)
Development
113,
825-839[Abstract]
32.
Foley, K.,
and Cooley, L.
(1998)
Development
125,
1075-1082[Abstract]
33.
Kumar, S.,
and Colussi, P. A.
(1999)
Trends Biochem. Sci.
24,
1-4[CrossRef][Medline]
[Order article via Infotrieve]
34.
Slee, E. A.,
Harte, M. T.,
Kluck, R. M.,
Wolf, B. B.,
Casiano, C. A.,
Newmeyer, D. D.,
Wang, H-G.,
Reed, J. C.,
Nicholson, D. W.,
Alnemri, E. S.,
Green, D. R.,
and Martin, S. J.
(1999)
J. Cell Biol.
144,
281-292
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Kondo, N. Senoo-Matsuda, Y. Hiromi, and M. Miura DRONC Coordinates Cell Death and Compensatory Proliferation. Mol. Cell. Biol., October 1, 2006; 26(19): 7258 - 7268. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Muro, D. L. Berry, J. R. Huh, C. H. Chen, H. Huang, S. J. Yoo, M. Guo, E. H. Baehrecke, and B. A. Hay The Drosophila caspase Ice is important for many apoptotic cell deaths and for spermatid individualization, a nonapoptotic process Development, September 1, 2006; 133(17): 3305 - 3315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kornbluth and K. White Apoptosis in Drosophila: neither fish nor fowl (nor man, nor worm) J. Cell Sci., May 1, 2005; 118(9): 1779 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar Migrate, Differentiate, Proliferate, or Die: Pleiotropic Functions of an Apical "Apoptotic Caspase" Sci. Signal., October 12, 2004; 2004(254): pe49 - pe49. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Muro, K. Monser, and R. J. Clem Mechanism of Dronc activation in Drosophila cells J. Cell Sci., October 1, 2004; 117(21): 5035 - 5041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cakouros, T. J. Daish, and S. Kumar Ecdysone receptor directly binds the promoter of the Drosophila caspase dronc, regulating its expression in specific tissues J. Cell Biol., June 7, 2004; 165(5): 631 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Forsyth, D. Lemongello, D. J. LaCount, P. D. Friesen, and A. J. Fisher Crystal Structure of an Invertebrate Caspase J. Biol. Chem., February 20, 2004; 279(8): 7001 - 7008. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, G.-H. Cha, S. Kim, J. H. Lee, J. Park, H. Koh, K.-Y. Choi, and J. Chung MKP-3 Has Essential Roles as a Negative Regulator of the Ras/Mitogen-Activated Protein Kinase Pathway during Drosophila Development Mol. Cell. Biol., January 15, 2004; 24(2): 573 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Martin and E. H. Baehrecke Caspases function in autophagic programmed cell death in Drosophila Development, January 15, 2004; 131(2): 275 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mergliano and J. S. Minden Caspase-independent cell engulfment mirrors cell death pattern in Drosophila embryos Development, December 1, 2003; 130(23): 5779 - 5789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ilangovan, W. L. Marshall, Y. Hua, and J. Zhou Inhibition of Apoptosis by Z-VAD-fmk in SMN-depleted S2 Cells J. Biol. Chem., August 15, 2003; 278(33): 30993 - 30999. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Fruscio, S. Styhler, E. Wikholm, M.-C. Boulanger, P. Lasko, and S. Richard kep1 interacts genetically with dredd/Caspase-8, and kep1 mutants alter the balance of dredd isoforms PNAS, February 18, 2003; 100(4): 1814 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cakouros, T. Daish, D. Martin, E. H. Baehrecke, and S. Kumar Ecdysone-induced expression of the caspase DRONC during hormone-dependent programmed cell death in Drosophila is regulated by Broad-Complex J. Cell Biol., June 10, 2002; 157(6): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gorski and M. Marra Programmed cell death takes flight: genetic and genomic approaches to gene discovery in Drosophila Physiol Genomics, May 10, 2002; 9(2): 59 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dorstyn, S. Read, D. Cakouros, J. R. Huh, B. A. Hay, and S. Kumar The role of cytochrome c in caspase activation in Drosophila melanogaster cells J. Cell Biol., March 18, 2002; 156(6): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. HOPWOOD, A. M. AHMED, A. POLWART, G. T. WILLIAMS, and H. HURD MALARIA-INDUCED APOPTOSIS IN MOSQUITO OVARIES: A MECHANISM TO CONTROL VECTOR EGG PRODUCTION J. Exp. Biol., March 10, 2002; 204(16): 2773 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee and E. Baehrecke Steroid regulation of autophagic programmed cell death during development Development, January 4, 2001; 128(8): 1443 - 1455. [Abstract] [PDF] |
||||
![]() |
H. Y. Chang and X. Yang Proteases for Cell Suicide: Functions and Regulation of Caspases Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 821 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zieler and J. A. Dvorak Invasion in vitro of mosquito midgut cells by the malaria parasite proceeds by a conserved mechanism and results in death of the invaded midgut cells PNAS, October 10, 2000; 97(21): 11516 - 11521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Vernooy, J. Copeland, N. Ghaboosi, E. E. Griffin, S. J. Yoo, and B. A. Hay Cell Death Regulation in Drosophila: Conservation of Mechanism and Unique Insights J. Cell Biol., July 24, 2000; 150(2): F69 - F76. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokoyama, N. Mukae, H. Sakahira, K. Okawa, A. Iwamatsu, and S. Nagata A Novel Activation Mechanism of Caspase-activated DNase from Drosophila melanogaster J. Biol. Chem., April 21, 2000; 275(17): 12978 - 12986. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Colussi, L. M. Quinn, D. C.S. Huang, M. Coombe, S. H. Read, H. Richardson, and S. Kumar Debcl, a Proapoptotic Bcl-2 Homologue, Is a Component of the Drosophila melanogaster Cell Death Machinery J. Cell Biol., February 21, 2000; 148(4): 703 - 714. [Abstract] [Full Text] [PDF] |
||||